Literature DB >> 16332976

Core erythropoietin receptor signals for late erythroblast development.

Madhu P Menon1, Jing Fang, Don M Wojchowski.   

Abstract

Critical signals for erythroblast formation are transduced by activated, tyrosine-phosphorylated erythropoietin receptor (EpoR) complexes. Nonetheless, steady-state erythropoiesis is supported effectively by EpoR alleles that are deficient in cytoplasmic phosphotyrosine sites. To better define core EpoR action mechanisms, signaling capacities of minimal PY-null (EpoR-HM) and PY343-retaining (EpoR-H) alleles were analyzed for the first time in bone marrow-derived erythroblasts. Jak2 activation via each allele was comparable. Stat5 (and several Stat5-response genes) were induced via EpoR-H but not via EpoR-HM. Stat1 and Stat3 activation was nominal for all EpoR forms. For both EpoR-HM and EpoR-H, Akt and p70S6-kinase activation was decreased multifold, and JNK activation was minimal. ERKs, however, were hyperactivated uniquely via EpoR-HM. In vivo, Epo expression in EpoR-HM mice was elevated, while Epo-induced reticulocyte production was diminished. In vitro, EpoR-HM erythroblast maturation also was attenuated (based on DNA content, forward-angle light scatter, and hemoglobinization). These EpoR-HM-specific defects were corrected not only upon PY343 site restoration in EpoR-H, but also upon MEK1,2 inhibition. Core EpoR PY site-independent signals for erythroblast formation therefore appear to be Stat5, Stat1, Stat3, p70S6-kinase, and JNK independent, but ERK dependent. Wild-type signaling capacities, however, depend further upon signals provided via an EpoR/PY343/Stat5 axis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16332976      PMCID: PMC1895369          DOI: 10.1182/blood-2005-02-0684

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  73 in total

1.  Efficiency of signalling through cytokine receptors depends critically on receptor orientation.

Authors:  R S Syed; S W Reid; C Li; J C Cheetham; K H Aoki; B Liu; H Zhan; T D Osslund; A J Chirino; J Zhang; J Finer-Moore; S Elliott; K Sitney; B A Katz; D J Matthews; J J Wendoloski; J Egrie; R M Stroud
Journal:  Nature       Date:  1998-10-01       Impact factor: 49.962

2.  MEK inhibitors: the chemistry and biological activity of U0126, its analogs, and cyclization products.

Authors:  J V Duncia; J B Santella; C A Higley; W J Pitts; J Wityak; W E Frietze; F W Rankin; J H Sun; R A Earl; A C Tabaka; C A Teleha; K F Blom; M F Favata; E J Manos; A J Daulerio; D A Stradley; K Horiuchi; R A Copeland; P A Scherle; J M Trzaskos; R L Magolda; G L Trainor; R R Wexler; F W Hobbs; R E Olson
Journal:  Bioorg Med Chem Lett       Date:  1998-10-20       Impact factor: 2.823

3.  Fetal anemia and apoptosis of red cell progenitors in Stat5a-/-5b-/- mice: a direct role for Stat5 in Bcl-X(L) induction.

Authors:  M Socolovsky; A E Fallon; S Wang; C Brugnara; H F Lodish
Journal:  Cell       Date:  1999-07-23       Impact factor: 41.582

4.  Activation of p38 MAP kinase and JNK but not ERK is required for erythropoietin-induced erythroid differentiation.

Authors:  Y Nagata; N Takahashi; R J Davis; K Todokoro
Journal:  Blood       Date:  1998-09-15       Impact factor: 22.113

5.  Identification of the erythropoietin receptor domain required for calcium channel activation.

Authors:  B A Miller; D L Barber; L L Bell; B K Beattie; M Y Zhang; B G Neel; M Yoakim; L I Rothblum; J Y Cheung
Journal:  J Biol Chem       Date:  1999-07-16       Impact factor: 5.157

6.  Crystallographic evidence for preformed dimers of erythropoietin receptor before ligand activation.

Authors:  O Livnah; E A Stura; S A Middleton; D L Johnson; L K Jolliffe; I A Wilson
Journal:  Science       Date:  1999-02-12       Impact factor: 47.728

7.  Proteasomes regulate erythropoietin receptor and signal transducer and activator of transcription 5 (STAT5) activation. Possible involvement of the ubiquitinated Cis protein.

Authors:  F Verdier; S Chrétien; O Muller; P Varlet; A Yoshimura; S Gisselbrecht; C Lacombe; P Mayeux
Journal:  J Biol Chem       Date:  1998-10-23       Impact factor: 5.157

8.  Tyrosine 425 within the activated erythropoietin receptor binds Syp, reduces the erythropoietin required for Syp tyrosine phosphorylation, and promotes mitogenesis.

Authors:  T Tauchi; J E Damen; K Toyama; G S Feng; H E Broxmeyer; G Krystal
Journal:  Blood       Date:  1996-06-01       Impact factor: 22.113

9.  Identification of a novel inhibitor of mitogen-activated protein kinase kinase.

Authors:  M F Favata; K Y Horiuchi; E J Manos; A J Daulerio; D A Stradley; W S Feeser; D E Van Dyk; W J Pitts; R A Earl; F Hobbs; R A Copeland; R L Magolda; P A Scherle; J M Trzaskos
Journal:  J Biol Chem       Date:  1998-07-17       Impact factor: 5.157

10.  Tyrosine 343 in the erythropoietin receptor positively regulates erythropoietin-induced cell proliferation and Stat5 activation.

Authors:  J E Damen; H Wakao; A Miyajima; J Krosl; R K Humphries; R L Cutler; G Krystal
Journal:  EMBO J       Date:  1995-11-15       Impact factor: 11.598

View more
  39 in total

1.  The SH2B1 adaptor protein associates with a proximal region of the erythropoietin receptor.

Authors:  Mojib Javadi; Edda Hofstätter; Natalie Stickle; Bryan K Beattie; Robert Jaster; Christin Carter-Su; Dwayne L Barber
Journal:  J Biol Chem       Date:  2012-06-05       Impact factor: 5.157

2.  Peginesatide and erythropoietin stimulate similar erythropoietin receptor-mediated signal transduction and gene induction events.

Authors:  Jennifer M Green; Karen Leu; Angela Worth; Richard B Mortensen; David K Martinez; Peter J Schatz; Don M Wojchowski; Peter R Young
Journal:  Exp Hematol       Date:  2012-03-06       Impact factor: 3.084

3.  Genome-wide identification of TAL1's functional targets: insights into its mechanisms of action in primary erythroid cells.

Authors:  Mira T Kassouf; Jim R Hughes; Stephen Taylor; Simon J McGowan; Shamit Soneji; Angela L Green; Paresh Vyas; Catherine Porcher
Journal:  Genome Res       Date:  2010-06-21       Impact factor: 9.043

Review 4.  Anemia, ineffective erythropoiesis, and hepcidin: interacting factors in abnormal iron metabolism leading to iron overload in β-thalassemia.

Authors:  Sara Gardenghi; Robert W Grady; Stefano Rivella
Journal:  Hematol Oncol Clin North Am       Date:  2010-10-15       Impact factor: 3.722

Review 5.  Erythropoietin receptor response circuits.

Authors:  Don M Wojchowski; Pradeep Sathyanarayana; Arvind Dev
Journal:  Curr Opin Hematol       Date:  2010-05       Impact factor: 3.284

6.  Future alternative therapies for β-thalassemia.

Authors:  Stefano Rivella; Eliezer Rachmilewitz
Journal:  Expert Rev Hematol       Date:  2009-12-01       Impact factor: 2.929

Review 7.  The Src homology 2 domain tyrosine phosphatases SHP-1 and SHP-2: diversified control of cell growth, inflammation, and injury.

Authors:  Z Z Chong; K Maiese
Journal:  Histol Histopathol       Date:  2007-11       Impact factor: 2.303

8.  BMP4, SCF, and hypoxia cooperatively regulate the expansion of murine stress erythroid progenitors.

Authors:  John M Perry; Omid F Harandi; Robert F Paulson
Journal:  Blood       Date:  2007-02-06       Impact factor: 22.113

9.  JAK2/Y343/STAT5 signaling axis is required for erythropoietin-mediated protection against ischemic injury in primary renal tubular epithelial cells.

Authors:  A C Breggia; D M Wojchowski; J Himmelfarb
Journal:  Am J Physiol Renal Physiol       Date:  2008-09-24

10.  EPO receptor circuits for primary erythroblast survival.

Authors:  Pradeep Sathyanarayana; Arvind Dev; Jing Fang; Estelle Houde; Olga Bogacheva; Oleg Bogachev; Madhu Menon; Sarah Browne; Anamika Pradeep; Christine Emerson; Don M Wojchowski
Journal:  Blood       Date:  2008-03-18       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.